News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cronos Therapeutics And Cancer Research Technology Announce New Anti-Cancer Drug Development Collaboration



3/27/2006 2:23:31 PM

Cronos Therapeutics Limited, a London based biopharmaceutical company, and Cancer Research Technology Limited, the specialist oncology development and commercialisation company owned by Cancer Research UK, today announce that they have entered into an agreement to develop a novel cancer therapy based on Cronos’ GeneICE platform technology.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES